Search Results - "FOLIN, Annika"
-
1
Risk of Acute Myeloid Leukemia and Myelodysplastic Syndrome in Trials of Adjuvant Epirubicin for Early Breast Cancer: Correlation With Doses of Epirubicin and Cyclophosphamide
Published in Journal of clinical oncology (20-06-2005)“…We reviewed follow-up of patients treated in 19 randomized trials of adjuvant epirubicin in early breast cancer to determine incidence, risk, and risk factors…”
Get full text
Journal Article -
2
Five-Year Results From a Scandinavian Sarcoma Group Study (SSG XIII) of Adjuvant Chemotherapy Combined With Accelerated Radiotherapy in High-Risk Soft Tissue Sarcoma of Extremities and Trunk Wall
Published in International journal of radiation oncology, biology, physics (01-12-2011)“…Purpose To evaluate adjuvant chemotherapy and interpolated accelerated radiotherapy (RT) for adult patients with high-risk soft tissue sarcoma in the…”
Get full text
Journal Article -
3
Sorafenib inhibits tumor growth and vascularization of rhabdomyosarcoma cells by blocking IGF-1R-mediated signaling
Published in OncoTargets and therapy (01-11-2008)“…The growth of many soft tissue sarcomas is dependent on aberrant growth factor signaling, which promotes their proliferation and motility. With this in mind,…”
Get full text
Journal Article -
4
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
Published in The oncologist (Dayton, Ohio) (01-05-2018)“…On August 28, 2015, a marketing authorization valid through the European Union was issued for panobinostat, in combination with bortezomib and dexamethasone,…”
Get full text
Journal Article -
5
EMA Review of Panobinostat (Farydak) for the Treatment of Adult Patients with Relapsed and/or Refractory Multiple Myeloma
Published in The oncologist (Dayton, Ohio) (01-07-2018)Get full text
Journal Article -
6
A retrospective safety analysis of adult patients treated with high-dose methotrexate for osteosarcoma in Stockholm, Sweden
Published in Journal of clinical oncology (20-05-2012)“…Abstract only 10083 Background: Patients with osteosarcoma are routinely treated with pre- and post-operative chemotherapy that includes high-dose…”
Get full text
Journal Article -
7
Five-year results from a Scandinavian sarcoma group study (SSG XIII) of adjuvant chemotherapy combined with accelerated radiotherapy in high-risk soft tissue sarcome of extremities and trunk wall
Published in International journal of radiation oncology, biology, physics (2011)“…Purpose: To evaluate adjuvant chemotherapy and interpolated accelerated radiotherapy (RT) for adult patients with high-risk soft tissue sarcoma in the…”
Get full text
Journal Article -
8
Long-term follow-up of 18 patients with myelodysplastic syndromes responding to recombinant erythropoietin treatment
Published in Leukemia research (2001)“…The outcome of continued EPO therapy was studied in 18 responding MDS patients. The EPO dose was reduced in a stepwise fashion to find the lowest possible…”
Get full text
Journal Article -
9
Comparison between histologic type, estrogen receptor, and nuclear DNA content in mammary carcinoma
Published in American journal of clinical oncology (01-02-1986)“…Histological specimens from 80 invasive breast carcinomas comprising typical cases of 16 ductal, nine papillary, 14 comedo, 13 colloid (mucous), 15 lobular,…”
Get more information
Journal Article -
10
Prognostic significance of nuclear DNA analysis in histological sections in mammary carcinoma
Published in American journal of clinical oncology (01-04-1986)“…The nuclear DNA content in tumor cells from invasive ductal breast carcinomas was analyzed in 26 patients who survived more than 10 years and in 23 patients…”
Get more information
Journal Article